D
Ascendis Pharma A/S ASND
$190.91 -$5.07-2.59% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 362.94% 2.05% 25.05% 21.61% -24.89%
Total Other Revenue -- -- -- -- --
Total Revenue 362.94% 2.05% 25.05% 21.61% -24.89%
Cost of Revenue 189.22% 124.34% -28.64% 53.14% -12.31%
Gross Profit 444.12% -8.43% 33.89% 15.88% -29.61%
SG&A Expenses 52.62% 46.67% 24.15% 10.88% 4.55%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 31.45% 37.12% -1.43% -14.42% -11.09%
Operating Income 58.10% -105.56% 101.04% 27.30% 6.44%
Income Before Tax 66.18% 29.43% 54.35% 38.63% 11.43%
Income Tax Expenses 1,671.68% -58.99% -81.45% 59.74% 152.78%
Earnings from Continuing Operations 62.54% 30.00% 56.16% 38.24% 10.93%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 62.54% 30.00% 56.16% 38.24% 10.93%
EBIT 58.10% -105.56% 101.04% 27.30% 6.44%
EBITDA 60.20% -116.30% 104.58% 28.05% 6.43%
EPS Basic 64.47% 33.65% 58.52% 39.59% 12.68%
Normalized Basic EPS 67.92% 33.12% 56.82% 39.97% 13.18%
EPS Diluted 64.47% 33.65% 58.52% 39.59% 12.68%
Normalized Diluted EPS 67.83% 33.12% 56.82% 39.97% 18.11%
Average Basic Shares Outstanding 5.42% 5.51% 5.70% 2.24% 2.01%
Average Diluted Shares Outstanding 5.11% 5.51% 5.70% 2.24% 8.15%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --